Search results
Promising trial data for Moderna's skin cancer vaccine sends stock rising
Quartz· 19 hours agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 1 day agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
...in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and...
Benzinga· 1 day agoPatient screening and enrollment are active, with the aim of enrolling 80 patients internationally in the overall Phase I/II trial.
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 20 hours agoTherapeutics, Inc. (NASDAQ:KTRA), has announced positive results from a Phase 1b trial of its...
Why it's so challenging to develop vaccines for parasitic diseases
BBC News· 4 hours agoThe process of making vaccines for parasites is extremely challenging – but scientists might be on...
ESHG: Neoantigen Vaccine Helps Prevent Cancer in Lynch Syndrome Patients
GenomeWeb News· 7 hours agoA neoantigen vaccine was able to prevent cancer in a subset of Lynch syndrome patients who mounted a T-cell response to one of the neoantigens, increasing their chance of ...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 4 days agoThe NHS has commenced a clinical trial offering personalised cancer vaccines being developed by BioNTech and Genentech to patients. The ...
ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Investing.com· 6 days agoICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 4 hours agoOn May 31, Pfizer announced the sort of clinical trial results that really get oncologists'...
...Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in...
Morningstar· 1 day ago(Nasdaq:KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced positive results from the primary analysis of TuHURA's ...